Delivery Order SPE2DB20D3505-SPE2DB25FU6V7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $76,320.98 to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector on April 23, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 24, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded a $7,760.84 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector units, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Taltz 80 mg/mL autoinjectors. The $22,414.01 award has a period of performance through March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,214.63 firm fixed-price delivery order for TALTZ 80 MG/ML auto-injector on November 7, 2025, with completion scheduled for November 10, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml autoinjector with a ceiling value of $7,605.54 under a firm fixed-price contract type. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a non-set-aside competitive award, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $4,133.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/mL auto-injector medication, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a $16,873.06 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml autoinjector medication, with a completion date of October 29, 2025. This competitive award uses firm fixed pricing and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FU6V7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,688.26 to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml auto-injectors, with a firm fixed price structure and an ultimate completion date of May 28, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The contract supports the company's role as a primary pharmaceutical vendor for federal military and healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense Logistics Agency's medical supply chain, delivering a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements for specialized pharmaceutical products, including immunological treatments like Taltz, through a flexible delivery order mechanism under its prime IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 5/27/25 |